ZC3H6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.237200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.894600E-01
Normal-vs-Stage2
4.127000E-01
Normal-vs-Stage3
2.396600E-01
Normal-vs-Stage4
4.209600E-01
Stage1-vs-Stage2
4.065800E-02
Stage1-vs-Stage3
2.228100E-02
Stage1-vs-Stage4
4.841000E-01
Stage2-vs-Stage3
5.272000E-02
Stage2-vs-Stage4
5.936800E-01
Stage3-vs-Stage4
1.070570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.319200E-01
Normal-vs-AfricanAmerican
4.652200E-01
Normal-vs-Asian
3.078600E-01
Caucasian-vs-AfricanAmerican
8.256800E-01
Caucasian-vs-Asian
6.072400E-02
AfricanAmerican-vs-Asian
1.694180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.158800E-01
Normal-vs-Female
4.368000E-01
Male-vs-Female
6.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.041400E-01
Normal-vs-Age(41-60Yrs)
4.939000E-01
Normal-vs-Age(61-80Yrs)
3.943000E-01
Normal-vs-Age(81-100Yrs)
3.700800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.003600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.010610E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.305700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.345800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.655600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.772200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.725600E-01
Normal-vs-Daily Drinker
3.968200E-01
Normal-vs-Weekly Drinker
3.606800E-01
Normal-vs-Occasional Drinker
4.271600E-01
Normal-vs-Social Drinker
4.544000E-01
Non Drinker-vs-Daily Drinker
7.183800E-01
Non Drinker-vs-Weekly Drinker
8.283200E-01
Non Drinker-vs-Occasional Drinker
4.095000E-01
Non Drinker-vs-Social Drinker
7.236500E-02
Daily Drinker-vs-Weekly Drinker
6.243600E-01
Daily Drinker-vs-Occasional Drinker
6.808800E-01
Daily Drinker-vs-Social Drinker
8.716300E-02
Weekly Drinker-vs-Occasional Drinker
3.555800E-01
Weekly Drinker-vs-Social Drinker
6.684400E-02
Occasional Drinker-vs-Social Drinker
1.842980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.158450E-01
Normal-vs-Grade 2
5.030400E-02
Normal-vs-Grade 3
1.916120E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.344400E-01
Grade 1-vs-Grade 3
6.373200E-01
Grade 1-vs-Grade 4
1.158450E-01
Grade 2-vs-Grade 3
4.290000E-01
Grade 2-vs-Grade 4
5.030400E-02
Grade 3-vs-Grade 4
1.916120E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.878200E-01
Normal-vs-NonDiabetic
4.084600E-01
Diabetic-vs-NonDiabetic
6.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.913000E-01
Normal-vs-NoPancreatitis
4.024800E-01
Pancreatitis-vs-NoPancreatitis
8.189400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.538800E-01
Normal-vs-N1
4.082800E-01
N0-vs-N1
3.984600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.672000E-01
Normal-vs-TP53-NonMutant
6.225600E-01
TP53-Mutant-vs-TP53-NonMutant
2.091600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
